Skip to main content

Therapy of gastric lymphoma of MALT type, including antibiotics

  • Chapter
Human Lymphoma: Clinical Implications of the REAL Classification
  • 60 Accesses

Abstract

This chapter addresses the systemic therapy of marginal B cell lymphoma, a category which comprises MALT-type lymphomas and monocytoid B cell lymphomas [20. 1]. These two different subtypes are approximately equal in frequency,1 but this chapter restricts its scope to lymphomas of the stomach.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Fisher RI, Dahlberg S, Nathwani BN, Banks PIVI, Miller TP, Grogan TM. A clinical analysis of two indolent lymphoma entities: mantle cell lymphoma and marginal zone lymphoma (including the mucosa-associated lymphoid tissue and monocytoid B-cell subcategories): a Southwest Oncology Group study. Blood 1995; 85:1075–82.

    CAS  PubMed  Google Scholar 

  2. Montalban C, Castrillo JM, Abraira V et al. Gastric B-cell mucosa-associated lymphoid tissue (MALT) lymphoma. Clinicopathological study and evaluation of the prognostic factors in 143 patients. Ann Oncol 1995; 6:355–62.

    CAS  PubMed  Google Scholar 

  3. Kath R, Donhuijsen K, Hayungs J, Albrecht K, Seeber S, Hoffken K. Primary gastric non-Hodgkin’s lymphoma: a clinicopathological study of 41 patients. J Cancer Res Clin Oncol 1995; 121:51–6.

    Article  CAS  PubMed  Google Scholar 

  4. Cogliatti SB, Schmid U, Schumacher U et al. Primary B-cell gastric lymphoma: a clinicopathological study of 145 patients. Gastroenterology 1991; 101:1159–70.

    CAS  PubMed  Google Scholar 

  5. Johnsson A, Brun E, Akerman M, Cavallin-Stahl E. Primary gastric non-Hodgkin’s lymphoma. A retrospective clinicopathological study. Acta Oncol 1992; 31: 525–31.

    Article  CAS  PubMed  Google Scholar 

  6. Castrillo JM, Montalban C, Obeso G, Piris MA, Rivas MC. Gastric B-cell mucosa associated lymphoid tissue lymphoma: a clinicopathological study in 56 patients. Gut 1992; 33: 1307–11.

    Article  CAS  PubMed  Google Scholar 

  7. Chan JK, Ng CS, Isaacson PG. Relationship between high-grade lymphoma and low-grade B-cell mucosa-associated lymphoid tissue lymphoma (MAL Toma) of the stomach.Am J Pathol 1990; 136:1153–64.

    CAS  PubMed  Google Scholar 

  8. Montalban C, Manzanal A, Castrillo JM, Escribano L, Bellas C. Low grade gastric B-cell MALT lymphoma progressing into high grade lymphoma. Clonal identity of the two stages of the tumour, unusual bone involvement and leukemic dissemination. Histopathology 1995; 27:89–91.

    Article  CAS  PubMed  Google Scholar 

  9. Bayerdörffer E, Neubauer A, Rudolph B et al. Regression of primary gastric lymphoma of mucosa-associated lymphoid tissue type after cure of Helicobacter pylori infection. MALT Lymphoma Study Group. Lancet 1995; 345:1591–4.

    Article  PubMed  Google Scholar 

  10. Montalban C, Manzanal A, Boixeda D, Redondo C, Bellas C. Treatment of low-grade gastric MALT lymphoma with Helicobacter pylori eradication. Lancet 1995; 345: 798–9.

    Article  CAS  PubMed  Google Scholar 

  11. Radaszkiewicz T, Dragosics B, Bauer P. Gastrointestinal malignant lymphomas of the mucosa-associated lymphoid tissue: factors relevant to prognosis. Gastroenterology 1992; 102: 1628–38.

    CAS  PubMed  Google Scholar 

  12. Gobbi PG, Dionigi P, Barbieri F et al. The role of surgery in the multimodal treatment of primary gastric non-Hodgkin’s lymphomas. A report of 76 cases and review of the literature. Cancer 1990; 65: 2528–36.

    Article  CAS  PubMed  Google Scholar 

  13. Fisher RI. CHOP chemotherapy as standard therapy for treatment of patients with diffuse histiocytic lymphoma. Important Adv Oncol 1990; 217–25.

    Google Scholar 

Further Reading

  • del Valle F, Hiddemann W, Willich N et al. (for the German Multicenter Study Group on GI-NHL). Clinical presentation of 371 primary gastrointestinal lymphoma: Results of a prospective multicenter study. Blood 1997; 90 (Suppl 1), 338a (abstract 1507).

    Google Scholar 

  • Koch P, del Valle F, Hiddemann W et al. (for the German Multicenter Study Group on GI-NHL). Primary gastrointestinal (GI) lymphoma in 371 patients: Data from a prospective multicentre study. Blood 1997; 90 (Suppl 1): 586a (abstract 2608).

    Google Scholar 

  • Koch P, Grothaus-Pinke B, Hiddemann W et al. (for the German Multicenter Study Group on GI-NHL). Primary lymphoma of the stomach: Three-year results of a prospective multicenter study. The German Multicenter Study Group on GI-NHL. Ann Oncol 1997; 8 (Suppl 1): S85–8.

    Article  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1999 Springer-Verlag London

About this chapter

Cite this chapter

Koch, P., Hiddemann, W. (1999). Therapy of gastric lymphoma of MALT type, including antibiotics. In: Mason, D.Y., Harris, N.L. (eds) Human Lymphoma: Clinical Implications of the REAL Classification. Springer, London. https://doi.org/10.1007/978-1-4471-0857-3_20

Download citation

  • DOI: https://doi.org/10.1007/978-1-4471-0857-3_20

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-4471-1218-1

  • Online ISBN: 978-1-4471-0857-3

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics